Introducing Imexpharm

Imexpharm Pharmaceutical Joint Stock Company, formerly known as Level II Pharmaceutical Company, has evolved over nearly five decades into Vietnam's leading pharmaceutical manufacturer, adhering to European standards. With a strong focus on investing in product quality in line with advanced global standards and pioneering innovations in the pharmaceutical industry, Imexpharm has firmly established itself at the forefront of the sector.

The company currently operates four factory clusters in Dong Thap, Ho Chi Minh City, and Binh Duong, with three of these clusters meeting EU-GMP standards and housing a total of 11 production lines.

Despite facing numerous challenges in the pharmaceutical industry and navigating the ups and downs of the nation's economy, Imexpharm remains steadfast in its original Mission and Commitment. The company aspires to elevate Vietnam's pharmaceutical sector to new heights by offering high-quality products that meet the country's healthcare needs at affordable prices, reducing the reliance on imported drugs.

Established in

1977

Factory cluster in Dong Thap, Binh Duong, Ho Chi Minh

The line meets EU-GMP standards

The factory cluster meets EU-GMP standards

Imexpharm Corporation

No.4, 30/4 Street, Ward 1, Cao Lanh City, Dong Thap Province

Abbreviated NameIMEXPHARM

Tax Code1400384433

Stock CodeIMP

Telephone0277-3851941

Emailimp@imexpharm.com

Websitewww.imexpharm.com

EU - GMP

Imexpharm proudly stands as the first pharmaceutical company in Vietnam to meet GMP-ASEAN standards and leads the country with the most EU-GMP certified factories. As a franchised production partner for major global pharmaceutical corporations, including Sandoz, Pharmacience Canada, and Sanofi-Aventis, Imexpharm is dedicated to ongoing technological advancements, product quality enhancement, and human resource development.

With three factory clusters and 11 production lines certified to EU-GMP standards, Imexpharm boasts the highest number of EU-GMP certified production lines in Vietnam. By the end of July 2024, the company had secured 28 MAUs (Market Authorization Units) for 11 products in Europe, further solidifying its international presence and credibility.

Imexpharm Culture

"1.000 years later, lotus still in bloom".

This cultural motto encapsulates Imexpharm's philosophy, determination, and steadfast commitment to customer service and community, all of which are deeply embedded in its strategic goals. Despite the challenges and obstacles faced in both life and business, Imexpharm remains confident in its ultimate success, much like the enduring strength and grace of the noble lotus. The lotus has become a powerful symbol of Imexpharm’s identity, brand, and people, representing resilience, excellence, and unwavering dedication.

Find out more

Our Journey

Imexpharm has been committed to sustainable development since its founding in 1977, focusing on balancing business success with the welfare of the community.

As a company that not only excels in operations but also cultivates a supportive work environment and unique corporate culture, Imexpharm lives by the philosophy, "1,000 years later, the lotus still blooms." This guiding principle emphasizes the importance of long-term sustainability and reinforces the company's dedication to aligning its business objectives with the well-being of the community.

Find out more

Our People

Human resources form the foundation of Imexpharm’s success and sustainable growth, making them a key focus of our investment.

At Imexpharm, we believe that our people are essential to our success. Our human resource development philosophy is built on three core pillars: "Expertise, Health, and Resilience." With this holistic approach, Imexpharm fosters a talented workforce with a positive attitude, strong knowledge, and outstanding skills, ensuring we are well-prepared for future challenges and continuous growth.

Find out more

Our Potential

Imexpharm’s core strengths lie in its talented workforce, financial stability, and a well-established distribution network.

Our People
At Imexpharm, we consider human resources to be a key factor in our success and sustainable growth. Our approach to human resource development is built on three pillars: “Expertise, Health, and Resilience.” With this comprehensive strategy, Imexpharm has nurtured a team defined by a positive mindset, deep expertise, and exceptional skills, ensuring we are well-equipped to meet the evolving demands of the industry

Finance/Capital
As of December 31, 2022, Imexpharm's financial strength is reflected in key indicators:

Charter Capital: VND 667 billion
Owner’s Equity: VND 1,894 billion
Total Net Revenue and Other Income: VND 1,668 billion
Total Assets: VND 2,277 billion
Profit Before Tax: VND 291.4 billion

Distribution System
With nearly five decades of establishment and growth, Imexpharm has developed a network of 20 sales branches stretching from North to South Vietnam. By enhancing team capacity, adopting advanced technology, and refining its operational model, Imexpharm's sales network has evolved into a professional, synchronized, and modern distribution system.